T he pathogenesis of postangioplasty restenosis involves migration and proliferation of vascular smooth muscle cells (VSMCs), which constitute a major component of postangioplasty neointimal lesions.
injury and its effect on VSMC migration and proliferation, which are key processes in neointima formation.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Impact of MMP8 on Cell Proliferation and Neointima Formation After Vessel Injury
To investigate whether MMP8 played a role in neointima formation, we used an established in vivo vascular injury model in which the endothelium of a segment of the carotid artery is removed with the use of a wire. [14] [15] [16] The study showed that at day 28, neointimal lesions in MMP8 knockout mice were significantly smaller than those in MMP8 wild-type mice ( Figure 1A ). We also examined cell proliferation in the injured carotid arteries at days 7 and 28, and found that there were significantly fewer proliferating cells in injured carotid arteries in MMP8 knockout mice than in MMP8 wild-type mice at day 7 ( 
Effect of MMP8 on Ex Vivo VSMC Proliferation and Migration
To verify that MMP8 has a positive effect on VSMC proliferation, we compared the rates of proliferation of cultured VSMCs isolated from aortas of MMP8 knockout and wildtype mice. Immunocytochemical staining and immunoblotting confirmed that cultured VSMCs from MMP8 wild-type mice expressed MMP8, whereas VSMCs from MMP8 knockout mice did not (Figure 2A and 2B). Proliferation assays showed that MMP8 knockout VSMCs had a significantly lower rate of proliferation than MMP8 wild-type VSMCs ( Figure 2C ). In agreement, immunostaining for the proliferation marker knockout VSMCs than that among MMP8 wild-type VSMCs ( Figure 2D ). In contrast, no significant difference was observed in terms of cell apoptosis between MMP8 wild-type and knockout VSMCs (data not shown).
To investigate whether MMP8 had an effect on VSMC migration, we performed in vitro scratch wound healing assays and Boyden chamber invasion assays on cultured VSMCs. The assays showed that compared with MMP8 wild-type VSMCs, MMP8 knockout VSMCs had significantly reduced migratory ability ( Figure 2E-2G ).
Proteomic Analysis of MMP8 Knockout and Wild-Type VSMC-Conditioned Culture Media
To investigate into molecular pathways involved in MMP8 regulation of VSMC proliferation and migration, we performed a mass spectrometry-based quantitative proteomic analysis on MMP8 knockout and wild-type VSMC-conditioned culture media. The assay detected 6 secreted/membrane proteins whose concentrations significantly differed in MMP8 knockout versus MMP8 wild-type VSMC-conditioned media (Table 1) . Among these proteins, a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) is of particular interest because there has been evidence indicating that it can promote cell proliferation and migration via the cadherin-β-catenin pathway. [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] ADAM10 has several structural domains including a signal peptide, a propeptide domain, a metalloproteinase domain, a disintegrin-like domain, a cystein-rich domain, a transmembrane domain, and a cytoplasmic domain. 28 The propeptide domain is cleaved off during ADAM10 maturation and activation. [28] [29] [30] [31] In the proteomics analysis, we found that MMP8 wild-type VSMCconditioned media had significantly higher concentrations of propeptide domain fragments than MMP8 knockout VSMC-conditioned media ( Table 2 ). In addition, we detected /apoE -/-and MMP8+/+/apoE -/-mice. Cells were subjected to immunofluorescent staining (A) and immunoblot analysis (B), both with an antibody against MMP8. C, Cells were cultured on 6-well plates (50 000 cells/well) for 4 days, harvested and counted; the column chart shows the means (±SEM) of cell counts in 4 independent experiments. D, Cells were subjected to immunofluorescent staining for nuclei using 4',6-diamidino-2-phenylindole and for the proliferation marker Ki-67 using a Ki-67 antibody; the column chart shows the means (±SEM) of Ki-67-positive cells in 4 independent experiments. E, Nearly confluent cells on 6-well plates were subjected to scratch wound healing assays; the column chart shows the means (±SEM) of migrated distance in 4 independent experiments. F, Cells were subjected to Boyden chamber invasion assays with fluorescent staining and quantification of migrated cells; the column chart shows the means (±SEM) of fluorescent intensity in 4 experiments. G, Cells (50 000 cells/insert) were subjected to migration assays and quantification of numbers of migrated cells; the column chart shows the means (±SEM) in 4 experiments. *P<0.05. fragments of other ectodomains of ADAM10 in MMP8 wildtype VSMC-conditioned media but not in MMP8 knockout VSMC-conditioned media ( Table 2 ).
Effect of MMP8 on ADAM10
Immunoblot analysis confirmed that MMP8 wild-type VSMC-conditioned media had significantly higher concentrations of ADAM10 propeptide than MMP8 knockout VSMC-conditioned media ( Figure 3A ), suggesting the possibility of an effect of MMP8 on ADAM10 propeptide domain cleavage. Therefore, we investigated whether there was a difference in the amount of mature ADAM10 (lacking the propeptide domain) versus the amount of pro-ADAM10 (full length, containing the propeptide domain) in MMP8 knockout and wild-type VSMCs. Immunoblot analysis showed that the amount of mature ADAM10 versus the amount of pro-ADAM10 was indeed greater in MMP8 wild-type VSMC extracts than in MMP8 knockout VSMC extracts ( Figure 3B ). The total intensity of the pro-ADAM10 band plus mature ADAM10 band was similar between the MMP8 wild-type and knockout VSMC extracts ( Figure 4B ), suggesting that MMP8 knockout did not lead to a change in ADAM10 expression. In agreement, flow cytometric and immunocytochemical analyses with an antibody against the ADAM10 propeptide domain both showed greater signals on MMP8 knockout VSMCs than on MMP8 wild-type VSMCs ( Figure 3C and 3D), consistent with the notion that MMP8 knockout VSMCs have larger amounts of unprocessed ADAM10 (containing the propeptide domain) than MMP8 wild-type VSMCs. To investigate whether ADAM10 might be involved in MMP8 regulation of VSMC proliferation and migration, we treated VSMCs with GI254023X, an ADAM10 specific inhibitor that binds the S1' specificity pocket of ADAM10 and prevents ADAM10 from shedding surface molecules on cells. 32 In these experiments, we found that GI254023X treatment did not alter ADAM10 protein level or propeptide cleavage (data not shown). The experiment showed that GI254023X significantly reduced proliferation and migration of MMP8 wild-type VSMCs but had no such effect on MMP8 knockout VSMCs ( Figure 4A-4C ). An additional experiment further demonstrated that knockdown of the endogenous ADAM10 with specific ADAM10 siRNA also reduced proliferation and migration of MMP8 wild-type VSMCs ( Figure 4D-4E) , supporting the notion that ADAM10 plays a role in MMP8 regulation of VSMC proliferation and migration.
We then performed proliferation and migration in the absence or presence of recombinant mouse ADAM10. The experiments showed that the addition of the recombinant ADAM10 rescued the proliferative and migratory ability of MMP8 knockout VSMCs ( Figure 5A and 5B), further supporting that ADAM10 plays a role in MMP8 regulation of VSMC proliferation and migration. wild-type and knockout VSMCs were cultured in the presence of GI254023X or the vehicle DMSO for 48 hours and subjected to immunofluorescent staining with an antibody against the proliferation marker Ki-67; the column chart shows the means (±SEM) of percentages of Ki-67-positive cells in 4 independent experiments. C, Nearly confluent MMP8 wild-type and knockout VSMCs cultured on 6-well plates in the presence of GI254023X or the vehicle DMSO were subjected to scratch wound healing assays; the column chart shows the means (±SEM) of migrated distance in 4 independent experiments. D, MMP8 wild-type and knockout VSMCs were transfected with ADAM10 siRNA or control siRNA and cultured on 6-well plates (50 000 cells/well) for 4 days, then harvested and counted; the column chart shows the means (±SEM) of cell counts in 4 independent experiments. E, Nearly confluent MMP8 wild-type and knockout VSMCs transfected with ADAM10 siRNA or control siRNA were cultured on 6-well plates and subjected to scratch wound healing assays; the column chart shows the means (±SEM) of migrated distance in 4 independent experiments. *P<0.05, **P<0.01. proliferation via the cadherin-β-catenin complex. [5] [6] [7] After the finding that MMP8 wild-type VSMCs had higher levels of mature ADAM10 than MMP8 knockout VSMCs, we investigated whether there were differences in the concentrations of N-cadherin and β-catenin between MMP8 wild-type and knockout VSMCs. We found that plasma membranes of MMP8 wild-type VSMCs contained less N-cadherin than plasma membranes of MMP8 knockout VSMCs, ( Figure 6A ) and that incubation of VSMCs with the ADAM10 inhibitor GI254023X increased the amounts of N-cadherin on plasma membranes ( Figure 6A ). In contrast, MMP8 wild-type VSMC-conditioned media had higher concentrations of N-cadherin than MMP8 knockout VSMC-conditioned media ( Figure 6B) .
Effect of MMP8 on N-
Knockdown of endogenous ADAM10 by siRNA resulted in a marked decrease in the amount of N-cadherin in conditioned media of MMP8 wild-type VSMCs ( Figure 6B ), whereas incubation of VSMCs with a recombinant ADAM10 led to a significant increase in N-cadherin concentration in conditioned media of MMP8 knockout VSMCs ( Figure 6B) .
It has been shown that N-cadherin shedding can result in dissociation of the cadherin-β-catenin complex and translocation of β-catenin into the nucleus where β-catenin interacts with a transcription factor complex to upregulate the expression of cell proliferation proteins such as cyclin D1 and WNT1 inducible signaling pathway protein 1 (WISP1). 5, 6, 33 In our study, we found that nuclei of MMP8 wild-type VSMCs had a higher concentration of β-catenin than nuclei of MMP8 knockout VSMCs ( Figure 6C ), and that its concentration was reduced if VSMCs were transfected with ADAM10 specific siRNA ( Figure 6C ). In addition, we found that compared with MMP8 knockout VSMCs, MMP8 wildtype VSMCs expressed the higher levels of the cell proliferation proteins cyclin D1 and WISP1 ( Figure 6D and 6E) , and that their levels were reduced when VSMCs were treated with GI254023X ( Figure 6D ) or transfected with ADAM10 specific siRNA ( Figure II in the online-only Data Supplement). In contrast, their expression levels in MMP8 knockout VSMCs were significantly increased if cells were cultured in the presence of a recombinant ADAM10 ( Figure 6E ).
ADAM10 and β-Catenin in Vessel Injury-Induced Neointima Lesions
To study the relationship of MMP8 with ADAM10, N-cadherin, and β-catenin in neointima formation, we examined the cellular location and temporal expression of ADAM10, N-cadherin, and β-catenin in carotid arteries of apoE 
Discussion
VSMC migration and proliferation is a key process in neointima formation responsible for postangioplasty restenosis. [1] [2] [3] [4] Our study shows that MMP8 promotes VSMC proliferation and migration. Using an established mouse model, we found that knockout of MMP8 significantly deterred neointima formation after vessel injury. Ex vivo experiments of VSMCs isolated from MMP8 knockout and wild-type mice, respectively, showed that MMP8 knockout resulted in VSMCs having decreased proliferative and migratory ability, indicating a positive effect of MMP8 on VSMC proliferation and migration. By proteomic analysis and follow-up experiments, we identified a molecular pathway mediating such effects of MMP8 on VSMCs. Specifically, we found that MMP8 knockout resulted in a reduction of the amount of mature ADAM10 versus the amount of pro-ADAM10, an increase of N-cadherin and β-catenin on the plasma membrane, a decrease in β-catenin translocation to the nucleus, and lower expression of the cell proliferation proteins cyclin D1 and WISP1. To our knowledge, this is the first report of a role of MMP8 in VSMC proliferation and migration and in neointima formation.
In this study, we found that MMP8 knockout VSMCconditioned media had significantly less ADAM10 propeptide and ectodomains than MMP8 wild-type VSMC-conditioned media. ADAM10 contains several structural domains including a signal peptide, a propeptide domain, a metalloproteinase domain, a disintegrin-like domain, a cystein-rich domain, a transmembrane domain, and a cytoplasmic domain. 28 The metalloproteinase domain has proteolytic activity, whereas the propeptide domain blocks the proteolytic active site in the metalloproteinase domain and is removed during ADAM10 maturation. 28, 29 The results of our study indicate that MMP8 has an effect on ADAM10 maturation in VSMCs. Activated ADAM10 can mediate shedding of some transmembrane proteins including N-cadherin. [17] [18] [19] [20] [21] Interestingly, ADAM10 itself is also subjected to shedding, which releases ADAM10 ectodomains from the plasma membrane, 30, 31 and the shedded ADAM10 ectodomains can function as a soluble protease with increased mobility. 30, 31 There is evidence indicating that ADAM10 ectodomain shedding in different tissues/cells requires different proteases; however, their identities are still unknown for most tissues/cells, apart from neuronal cells where ADAM10 can be shedded by ADAM9 and ADAM15. 30 The results of our study implicate MMP8 in ADAM10 shedding in VSMCs.
We found that plasma membranes of MMP8 wild-type VSMCs contained substantially less N-cadherin than plasma membranes of MMP8 knockout VSMCs, whereas MMP8 wild-type VSMC-conditioned media had higher concentrations of N-cadherin than MMP8 knockout VSMC-conditioned media, and that incubation of VSMCs with the ADAM10 inhibitor GI254023X increased the amounts of N-cadherin on plasma membranes whereas knockdown of ADAM10 in VSMCs reduced the amount of N-cadherin in conditioned media of MMP8 wild-type VSMCs. These findings suggest that the effect of MMP8 on N-cadherin shedding is mediated, at least in part, by ADAM10. Interestingly, a previous study showed that MMP9 and MMP12, but not MMP2 or MMP14, can cause N-cadherin shedding on VSMCs. 34 Thus, it seems that MMP9 and MMP12 can shed N-cadherin, whereas MMP8 can promote N-cadherin shedding by ADMA10.
An important role of N-cadherin in modulating VSMC proliferation via the β-catenin signaling pathway has been elegantly demonstrated by other investigators. 5, 6 On the plasma membrane, N-cadherin interacts with β-catenin, forming cadherin-β-catenin complexes. Cleavage of N-cadherin results in dissociation of these 2 proteins, allowing β-catenin to be translocated into the nucleus, where β-catenin interacts with the transcription factor T cell-specific transcription factor 5, 6, [35] [36] [37] and thereby regulates the transcription of several genes that encode proteins involved in cell proliferation, such as cyclin D1 and WISP1. 5, 6, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] 33, [35] [36] [37] In this study, we found that MMP8 wild-type VSMCs contained substantially less β-catenin in the plasma membrane than MMP8 knockout VSMCs, whereas nuclei of MMP8 wild-type VSMCs had more β-catenin than nuclei of MMP8 knockout VSMCs. In agreement, the expression levels of the cell proliferation proteins cyclin D1 and WISP1 were higher in MMP8 wildtype VSMCs. We also found that inhibition of ADAM10 activity by GI254023X substantially increased the amount of β-catenin in the plasma membrane and that knockdown of ADAM10 by siRNA markedly reduced the amount of β-catenin in the nucleus of MMP8 wild-type VSMCs and the expression levels of cyclin D1 and WISP1 in these cells. These findings are consistent with an effect of MMP8 on β-catenin signaling, mediated by ADAM10. It is noteworthy that such an effect has also been observed in stem/progenitor cells as we reported recently. 9 Some other members of the MMP family have also been reported to have important roles in VSMC proliferation. It has been shown that VSMCs isolated from MMP9 knockout mice have a significantly lower proliferation rate than VSMCs from wild-type mice, 38 and that MMP9 and MMP12 promote VSMC proliferation by shedding N-cadherin and activating the β-catenin signaling pathway. 34 Meanwhile, MMP2 and MMP14 have been shown to play a role in oxidized low density lipoprotein-induced VSMC proliferation involving a sphingomyelin/ ceramide signaling pathway. 39 The difference in VSMC proliferation between MMP8 wild-type and knockout is not attributable to a change in the expression of those MMPs because we showed in our previous study that there is no difference in their expression between MMP8 wild-type and knockout. 13 Migration of VSMCs from the arterial media to the intima is also an important process in the development of vascular lesions, especially neointima formation underlying restenosis or in stent-restenosis after angioplasty or stent implantation. Our study showed that MMP8 wild-type VSMCs had greater migratory ability than MMP8 knockout VSMCs, and that this difference was abolished by the ADAM10 inhibitor GI254023X or ADAM10 knockdown by siRNA, whereas the reduced migratory ability of MMP8 knockout VSMCs could be rescued by incubating cells with a recombinant ADAM10. These findings suggest that MMP8 has an effect on VSMC migration via its effect on ADAM10. This is consistent with the findings of other studies showing that ADAM10 can disrupt cell-cell adhesion attributable to its effect on cadherins and thereby facilitate cell migration. 17, 22, 26 In addition to ADAM10, several other proteins also showed significantly different concentrations between MMP8 knockout and wild-type VSMC-conditioned media in the proteomic analysis, including ADAMTS-like protein 2, cell growth regulator with EF hand domain protein 1, collagen α-2(V) chain, retinoid-inducible serine carboxypeptidase, and SCOspondin. However, the biological functions of these proteins are largely unknown.
In summary, our study demonstrates that MMP8 plays an important role in neointima formation after vessel injury. Although it is likely that the overall contribution of MMP8 to its pathogenesis would involve multiple cell types and mechanisms, the results of our study indicate that MMP8 modules VSMC proliferation and migration and that this is at least partly via its effect on ADAM10 and consequently on N-cadherin and the β-catenin signaling pathway.
